Post-authorization Surveillance of Medical Products during a Pandemic Emergency, 21 July 2020
Gov't Doc #
MetadataShow full item record
Other Language Versions
The purpose of this report is to furnish guidance and recommendations to support regulatory decision-making in pharmacovigilance, technovigilance, and hemovigilance during pandemics in the Region of the Americas. Furthermore, given the heightened importance of improving the detection, prevention, and response to unregistered, substandard, or falsified medical products in this context, it addresses key issues in this regard. This report is designed for national regulatory authorities (NRAs) and other actors (Expanded Program on Immunization, disease-specific and public health programs, health service professionals, etc.) involved in the regulation, selection, indication, and utilization of health technologies. Although this report discusses both medicines (including vaccines) and medical devices, the steps prior to their use and conditions of authorization, as well as post-authorization surveillance, are clearly very different for each of these health technologies. Since post-authorization surveillance is a regulatory function of the health authorities, the report describes common approaches for the different types of technologies, as well as aspects specific to each one. The market surveillance components associated with importation/exportation, distribution, regulation of promotion and advertising, quality control, and inspection are beyond the scope of this report, unless they are related to the main components mentioned.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Pan American Health Organization; Health Systems and Services (HSS) (Washington, D.C., PAHO, 2020-06-05)This document provides national regulatory authorities (NRAs) with guidance for the regulation of clinical trials (CTs) in order to promote the investigation and use of safe and efficacious medicines and other health ...
Pan American Health Organization; Health Emergencies (PHE) (Washington, D.C., PAHO, 2020-08-24)Regional. PAHO continued to collaborate with its partners within the Region and across the globe to deliver technical cooperation, evidence-based guidance, and recommendations, and to advocate for the Americas on the global ...
Reliance for Emergency Use Authorization of Medicines and Other Health Technologies in a Pandemic (e.g. COVID-19) Pan American Health Organization; Health Systems and Services (HSS) (Washington, D.C., PAHO, 2020-04-23)Purpose and Context: This document provides guidance to national regulatory authorities (NRAs) and regulatory systems on practical ways to implement reliance for emergency use of medicines and other health technologies in ...